Hjem › Akut myelogen leukemi › New York › Staten Island
Kliniske studier for Akut myelogen leukemi i Staten Island, NY
14 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Staten Island (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi unna
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
RekruttererFase 1
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi unna
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi unna
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi unna
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi unna
A Study of CRD3874-SI in People With Leukemia
RekruttererFase 1
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown · 12 mi unna
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi unna
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
RekruttererFase 2
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi unna
A Study of Revumenib and Mezigdomide in People With Leukemia
RekruttererFase 1/2
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi unna
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
RekruttererFase 1
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown · 12 mi unna
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
RekruttererFase 1
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi unna
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
RekruttererFase 1
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown · 12 mi unna
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
RekruttererFase 1
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi unna
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
RekruttererFase 2
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi unna
Akut myelogen leukemi-studier i andre byer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Seattle, WA41 studier
- Baldwin Park, CA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA31 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
Andre studier i Staten Island
- Brystkreft40 studier
- Ikke-småcellet lungekreft19 studier
- Prostatakreft16 studier
- Multipelt myelom13 studier
- Lungekreft12 studier
- Blærekreft11 studier
- Kreft (alle typer)11 studier
- Endometriekreft11 studier
- Metastatisk kreft10 studier
- Eggstokkreft9 studier
- Plateepitelcancer i hode og hals9 studier
- Lymfom8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.